These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 23826971)

  • 1. Nanoparticle-mediated delivery of therapeutic genes: focus on miRNA therapeutics.
    Muthiah M; Park IK; Cho CS
    Expert Opin Drug Deliv; 2013 Sep; 10(9):1259-73. PubMed ID: 23826971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polyethylenimines for siRNA and miRNA delivery in vivo.
    Höbel S; Aigner A
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2013; 5(5):484-501. PubMed ID: 23720168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progress in microRNA delivery.
    Zhang Y; Wang Z; Gemeinhart RA
    J Control Release; 2013 Dec; 172(3):962-74. PubMed ID: 24075926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-targeted therapeutics for lung cancer treatment.
    Xue J; Yang J; Luo M; Cho WC; Liu X
    Expert Opin Drug Discov; 2017 Feb; 12(2):141-157. PubMed ID: 27866431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strategies to antagonize miRNA functions in vitro and in vivo.
    Baigude H; Rana TM
    Nanomedicine (Lond); 2014 Nov; 9(16):2545-55. PubMed ID: 25490425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymer-based delivery of RNA-based therapeutics in ovarian cancer.
    Weirauch U; Gutsch D; Höbel S; Aigner A
    Methods Mol Biol; 2013; 1049():443-65. PubMed ID: 23913237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring the interaction between small RNAs and R genes during Brachypodium response to Fusarium culmorum infection.
    Lucas SJ; Baştaş K; Budak H
    Gene; 2014 Feb; 536(2):254-64. PubMed ID: 24368332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-transcriptional gene-expression regulation by micro RNA (miRNA) network in renal disease.
    Kaucsár T; Rácz Z; Hamar P
    Adv Drug Deliv Rev; 2010 Nov; 62(14):1390-401. PubMed ID: 20940025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanoparticle-mediated delivery of microRNAs-based therapies for treatment of disorders.
    Ghafouri-Fard S; Shoorei H; Noferesti L; Hussen BM; Moghadam MHB; Taheri M; Rashnoo F
    Pathol Res Pract; 2023 Aug; 248():154667. PubMed ID: 37422972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid nanocarriers for microRNA delivery.
    Scheideler M; Vidakovic I; Prassl R
    Chem Phys Lipids; 2020 Jan; 226():104837. PubMed ID: 31689410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanocarriers for delivery of siRNA and co-delivery of siRNA and other therapeutic agents.
    Zhao J; Feng SS
    Nanomedicine (Lond); 2015 Jul; 10(14):2199-228. PubMed ID: 26214357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultrasound-guided therapeutic modulation of hepatocellular carcinoma using complementary microRNAs.
    Mullick Chowdhury S; Wang TY; Bachawal S; Devulapally R; Choe JW; Abou Elkacem L; Yakub BK; Wang DS; Tian L; Paulmurugan R; Willmann JK
    J Control Release; 2016 Sep; 238():272-280. PubMed ID: 27503707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vectors and methods for hairpin RNA and artificial microRNA-mediated gene silencing in plants.
    Eamens AL; Waterhouse PM
    Methods Mol Biol; 2011; 701():179-97. PubMed ID: 21181531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-targeting multifunctional nanoparticles for siRNA delivery: recent advances in cancer therapy.
    Ku SH; Kim K; Choi K; Kim SH; Kwon IC
    Adv Healthc Mater; 2014 Aug; 3(8):1182-93. PubMed ID: 24577795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delivery of miRNAs Using Nanoparticles for the Treatment of Osteosarcoma.
    Wang C; Zhang Y; Kong W; Rong X; Zhong Z; Jiang L; Chen S; Li C; Zhang F; Jiang J
    Int J Nanomedicine; 2024; 19():8641-8660. PubMed ID: 39188861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exosome-mediated small RNA delivery for gene therapy.
    Zhou Y; Zhou G; Tian C; Jiang W; Jin L; Zhang C; Chen X
    Wiley Interdiscip Rev RNA; 2016 Nov; 7(6):758-771. PubMed ID: 27196002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploiting microRNAs As Cancer Therapeutics.
    Robb T; Reid G; Blenkiron C
    Target Oncol; 2017 Apr; 12(2):163-178. PubMed ID: 28138797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The potential and advances in RNAi therapy: chemical and structural modifications of siRNA molecules and use of biocompatible nanocarriers.
    Joo MK; Yhee JY; Kim SH; Kim K
    J Control Release; 2014 Nov; 193():113-21. PubMed ID: 24862319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNAs as new therapeutic targets and tools in cancer.
    Gandellini P; Profumo V; Folini M; Zaffaroni N
    Expert Opin Ther Targets; 2011 Mar; 15(3):265-79. PubMed ID: 21208133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanodelivery systems for nucleic acid therapeutics in drug resistant tumors.
    Iyer AK; Duan Z; Amiji MM
    Mol Pharm; 2014 Aug; 11(8):2511-26. PubMed ID: 24661041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.